News/Compliance & Enforcement/Biogen Inc. Agrees to Pay $900 Million for Alleged Kickbacks to Prescribe Their MS Drugs

False Claims Act·Compliance & Enforcement Brief

Biogen Inc. Agrees to Pay $900 Million for Alleged Kickbacks to Prescribe Their MS Drugs

PubK AdminSeptember 29, 2022 · 1 min read

🔒 Members Only

Pharmaceutical company Biogen Inc.

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.

$750/year

Become a Member

Not ready to join? Take the free Pub K Weekly digest.One email. Free. Top industry articles, the community calendar, and the latest job postings.